Marek Weiler
Impact in
- Drug Discovery top 10%
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 5
-
- Ultrasound and Hyperthermia Applications 8
- Characterization and Applications of Magnetic Nanoparticles 3
- Nanoplatforms for cancer theranostics 2
- Bone Tissue Engineering Materials 1
- Co-authors
- Fabian M. Kiessling (12 shared papers)Twan Lammers (11 shared papers)Donald J. Jenden (1 shared paper)Gerrit Storm (3 shared papers)Richard Scott Jope (1 shared paper)Stephan Rütten (4 shared papers)Josbert M. Metselaar (2 shared papers)Jiong‐Wei Wang (1 shared paper)
- Journals
- Journal of Controlled Release (2 papers)Biomacromolecules (1 paper)HemaSphere (1 paper)Pharmaceutics (1 paper)ACS Biomaterials Science & Engineering (1 paper)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Marek Weiler
20 papers receiving 478 citations
Peers
Comparison fields: 5 of 64
- Drug Discovery 8
- Biomaterials 116
- Biomedical Engineering 206
- Pharmaceutical Science 30
- Pharmacology 36
Countries citing papers authored by Marek Weiler
This map shows the geographic impact of Marek Weiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Weiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Weiler more than expected).
Fields of papers citing papers by Marek Weiler
This network shows the impact of papers produced by Marek Weiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Weiler. The network helps show where Marek Weiler may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Weiler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 136 | |
| 2 | 1978 | 41 | |
| 3 | 2022 | 36 | |
| 4 | 2023 | 34 | |
| 5 | 2016 | 33 | |
| 6 | 2021 | 29 | |
| 7 | 2019 | 27 | |
| 8 | 2022 | 26 | |
| 9 | 2022 | 26 | |
| 10 | 2023 | 18 | |
| 11 | 2024 | 18 | |
| 12 | 2022 | 16 | |
| 13 | 2023 | 16 | |
| 14 | 2015 | 10 | |
| 15 | 2022 | 7 | |
| 16 | 2012 | 6 | |
| 17 | 2024 | 5 | |
| 18 | 2023 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2026 | 2 |
About Marek Weiler
Marek Weiler is a scholar working on Biomaterials, Biomedical Engineering, Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics, having authored 22 papers that have together received 490 indexed citations. Recurring topics across this work include Ultrasound and Hyperthermia Applications (8 papers), Nanoparticle-Based Drug Delivery (5 papers), Characterization and Applications of Magnetic Nanoparticles (3 papers), Bone Metabolism and Diseases (2 papers), Nanoplatforms for cancer theranostics (2 papers), Radiopharmaceutical Chemistry and Applications (1 paper), Bone health and osteoporosis research (1 paper) and Bone Tissue Engineering Materials (1 paper). The work is most often cited by research in Drug Discovery (8 citations), Biomaterials (116 citations), Biomedical Engineering (206 citations), Pharmaceutical Science (30 citations) and Pharmacology (36 citations). Marek Weiler has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Fabian M. Kiessling, Twan Lammers, Donald J. Jenden, Gerrit Storm, Richard Scott Jope, Stephan Rütten, Josbert M. Metselaar, Jiong‐Wei Wang, Dominique P.V. de Kleijn and Raymond Michel Schiffelers. Their work appears in journals such as Journal of Controlled Release, Biomacromolecules, HemaSphere, Pharmaceutics and ACS Biomaterials Science & Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.